307 participants
Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-09-10
- Start Date:
- 2012-10-18
- Completion:
- 2014-12-23
Conditions
- Type 2 Diabetes Mellitus
Interventions
- DRUG